These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
604 related articles for article (PubMed ID: 35659970)
1. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes. Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871 [TBL] [Abstract][Full Text] [Related]
3. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein. Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313 [TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models. Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726 [TBL] [Abstract][Full Text] [Related]
5. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates. Mi Z; Gong L; Kong Y; Zhao P; Yin Y; Xu H; Tian L; Liu Z Platelets; 2022 Nov; 33(8):1260-1269. PubMed ID: 35968647 [TBL] [Abstract][Full Text] [Related]
7. Uncovering essential anesthetics-induced exosomal miRNAs related to hepatocellular carcinoma progression: a bioinformatic investigation. Huang N; Fang J; Du F; Zhou J; Li Y; Zhang X BMC Med Genomics; 2024 Jun; 17(1):154. PubMed ID: 38840234 [TBL] [Abstract][Full Text] [Related]
8. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma. Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235 [TBL] [Abstract][Full Text] [Related]
9. Serum exosomal microRNA-370-3p and microRNA-196a-5p are potential biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Wei Y; Zhang Q; An L; Fang G; Hong D; Jiao T; Yang H; Wang Z Folia Histochem Cytobiol; 2022; 60(3):215-225. PubMed ID: 35762276 [TBL] [Abstract][Full Text] [Related]
10. Expression profile of serum-related exosomal miRNAs from parathyroid tumor. Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma. Xue X; Zhao Y; Wang X; Qin L; Hu R J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497 [TBL] [Abstract][Full Text] [Related]
12. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma. Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598 [TBL] [Abstract][Full Text] [Related]
13. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2. Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714 [TBL] [Abstract][Full Text] [Related]
14. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer. Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847 [TBL] [Abstract][Full Text] [Related]
15. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis. Liu C; Ren C; Guo L; Yang C; Yu Q Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986 [TBL] [Abstract][Full Text] [Related]
16. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma. Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value. Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302 [TBL] [Abstract][Full Text] [Related]
18. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma. Hu Z; You L; Hu S; Yu L; Gao Y; Li L; Zhang S Int Immunopharmacol; 2024 Jan; 126():111149. PubMed ID: 38006750 [TBL] [Abstract][Full Text] [Related]
20. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]